Related Experiment Videos
Production of recombinant soluble human integrin alpha4beta1
1Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, University of Manchester, 2.205 Stopford Building, Oxford Road, Manchester, UK.
FEBS Letters
|April 18, 2000
Summary
Researchers created a soluble alpha4beta1 integrin, a key molecule in inflammation. This recombinant protein is folded correctly and binds ligands, enabling anti-inflammatory drug screening and structural studies.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Integrin alpha4beta1 is a critical leukocyte adhesion receptor.
- It is a significant target for developing anti-inflammatory therapeutics.
Purpose of the Study:
- Generate a recombinant soluble alpha4beta1 receptor.
- Enable high-throughput screening assays for inhibitors.
- Facilitate crystallisation trials and structure determination.
Main Methods:
- Site-directed mutagenesis to truncate subunits before transmembrane domains.
- Expression using baculovirus infection of insect cells.
- ELISA and solid-phase ligand-binding assays to assess folding and function.
Main Results:
- Recombinant subunits exhibited expected molecular weights.
- Alpha4 subunit showed proteolytic processing, similar to the native form.
- Soluble integrin demonstrated correct folding and functional ligand binding.
Conclusions:
- The recombinant soluble alpha4beta1 integrin is a functional and correctly folded molecule.
- This reagent is suitable for high-throughput screening and structural studies.
- It advances the development of novel anti-inflammatory therapeutics.